Global $2.88 Billion Proton Therapy Systems Market Analysis 2014-2017 & Forecasts to 2025

DUBLIN, August 25, 2017 /PRNewswire/ --

The "Proton Therapy Systems Market Analysis By Product (Equipment, Services), By Type (Single-Room Systems, Multiroom Systems), By Region (North America, Europe, Asia Pacific, LATAM, MEA), And Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

The global proton therapy systems market is expected to reach USD 2.88 billion by 2025

The market is primarily driven by increasing number of proton therapy centers, rising number of cancer cases, and growing investments by hospitals to establish these centers.

Growing funds & investments by hospitals, manufacturers, and private investors are also contributing to the growth of this market. For instance, in August 2015, Mevion Medical Systems (U.S.) raised USD 200 million in an equity funding led by HOPU Investments (China) and YuanMing Capital (China). These funds are likely to be used for development of technologically advanced and low-cost products. Furthermore, governments across various geographies are including budgets for establishment of these centers. For instance, in July 2015, the state government of Victoria included nearly AUD 2 million (USD 1.53 million) to develop a National Centre for Proton Beam Therapy at the Victorian Comprehensive Cancer Centre (VCCC). The new center is expected to offer treatment to the patients in Australia.

In addition, rapid increase in the number of cancer cases globally is anticipated to bolster market growth during the forecast period. According to American Cancer Society, an estimated 1,688,780 new cancer cases are expected to be diagnosed in the U.S. and this disorder is likely to cause nearly 600,920 deaths in 2017. Furthermore, according to The Lancet, the number of women diagnosed with breast tumors is estimated to reach 3.2 million by 2030, which is almost double of 1.7 million in 2015.

Favorable reimbursement policies in the U.S and European countries and rising cancer-related healthcare expenditure in emerging nations is likely to propel the global market. In addition, decreasing cost of proton therapy, increasing awareness, and rising adoption are expected to boost demand for these systems during the forecast period. However, high costs involved in the establishment of these centers and lack of reimbursement in emerging nations is likely to restrain growth in the coming years.

Key Topics Covered:

1 Research Methodology

2. Executive Summary

3. Proton Therapy Systems Market Variables, Trends & Scope

4. Proton Therapy Systems Market: Product Estimates & Trend Analysis

5. Proton Therapy Systems Market: Type Estimates & Trend Analysis

6. Proton Therapy Systems Market: Regional Estimates & Trend Analysis, and By Product

7. Competitive Landscape

• Ion Beam Applications S.A.
• Optivus Proton Therapy, Inc.
• Mevion Medical Systems
• Advanced Oncotherapy plc
• Varian Medical Systems, Inc.
• ProTom International, Inc.
• Hitachi, Ltd.
• Mitsubishi Corporation
• ProNova Solutions, LLC (A division of Provision Healthcare, LLC)
• Sumitomo Heavy Industries, Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/86bxkr/proton_therapy

Media Contact:

Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]